AMERISAFE Current Deferred Revenue vs Capital Surpluse Analysis

AMSF Stock

USD 58.69 0.62 1.07%

AMERISAFE financial indicator trend analysis is way more than just evaluating AMERISAFE prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AMERISAFE is a good investment. Please check the relationship between AMERISAFE Current Deferred Revenue and its Capital Surpluse accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AMERISAFE. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more detail on how to invest in AMERISAFE Stock please use our How to Invest in AMERISAFE guide.

Current Deferred Revenue vs Capital Surpluse

Current Deferred Revenue vs Capital Surpluse Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AMERISAFE Current Deferred Revenue account and Capital Surpluse. At this time, the significance of the direction appears to have very strong relationship.

The correlation between AMERISAFE's Current Deferred Revenue and Capital Surpluse is 0.81. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of AMERISAFE, assuming nothing else is changed. The correlation between historical values of AMERISAFE's Current Deferred Revenue and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of AMERISAFE are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Current Deferred Revenue i.e., AMERISAFE's Current Deferred Revenue and Capital Surpluse go up and down completely randomly.

Correlation Coefficient

0.81

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Capital Surpluse

Most indicators from AMERISAFE's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AMERISAFE current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AMERISAFE. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more detail on how to invest in AMERISAFE Stock please use our How to Invest in AMERISAFE guide.At this time, AMERISAFE's Enterprise Value Multiple is most likely to increase significantly in the upcoming years.

	2021	2022	2023	2024 (projected)
Gross Profit	265.2M	244.1M	306.9M	291.0M
Total Revenue	316.0M	294.7M	306.9M	329.6M

Gross Profit Total Revenue

AMERISAFE fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Cash	Other Current Liab	Total Current Liabilities	Other Liab	Accounts Payable	Long Term Debt	Common Stock Total Equity	Common Stock
Total Assets		0.01	0.95	0.12	-0.58	0.84	0.09	-0.56	0.15	-0.16	0.91	-0.63	0.55	0.72	0.96	0.35	0.1	0.63	0.18	-0.08	-0.07	0.23	0.64	0.55	0.91	0.91
Short Long Term Debt Total	0.01		0.21	0.49	-0.58	0.39	-0.57	0.13	0.57	0.05	-0.02	-0.14	-0.16	0.05	-0.06	0.32	0.48	-0.02	0.73	-0.28	-0.32	-0.72	-0.57	-0.29	-0.01	-0.01
Total Stockholder Equity	0.95	0.21		0.18	-0.67	0.95	-0.16	-0.45	0.41	-0.18	0.81	-0.54	0.55	0.73	0.88	0.3	0.13	0.52	0.32	-0.29	-0.28	0.07	0.43	0.38	0.81	0.81
Property Plant And Equipment Net	0.12	0.49	0.18		-0.5	0.19	-0.14	0.13	0.2	0.42	0.07	-0.57	0.14	-0.3	0.22	0.27	0.81	-0.08	0.61	0.0	0.01	-0.76	-0.29	-0.26	0.3	0.3
Net Debt	-0.58	-0.58	-0.67	-0.5		-0.69	0.26	0.14	-0.4	0.35	-0.64	0.44	0.09	-0.51	-0.54	-0.3	-0.41	-0.35	-0.88	0.23	0.23	0.3	-0.08	-0.13	-0.53	-0.53
Retained Earnings	0.84	0.39	0.95	0.19	-0.69		-0.38	-0.34	0.58	-0.24	0.67	-0.45	0.47	0.7	0.7	0.35	0.1	0.5	0.44	-0.41	-0.42	-0.08	0.17	0.21	0.63	0.63
Non Current Assets Total	0.09	-0.57	-0.16	-0.14	0.26	-0.38		-0.56	-0.95	0.18	0.29	-0.37	-0.07	0.06	0.22	-0.14	0.09	0.03	-0.38	0.84	0.87	0.38	0.62	0.48	0.29	0.3
Non Currrent Assets Other	-0.56	0.13	-0.45	0.13	0.14	-0.34	-0.56		0.4	-0.19	-0.58	0.61	-0.28	-0.67	-0.55	-0.19	-0.28	-0.31	0.08	-0.61	-0.6	-0.18	-0.51	-0.41	-0.61	-0.61
Other Assets	0.15	0.57	0.41	0.2	-0.4	0.58	-0.95	0.4		-0.18	-0.1	0.19	0.24	0.11	0.02	0.09	-0.04	-0.02	0.43	-0.86	-0.89	-0.36	-0.47	-0.39	-0.07	-0.08
Cash And Short Term Investments	-0.16	0.05	-0.18	0.42	0.35	-0.24	0.18	-0.19	-0.18		-0.34	-0.35	0.52	-0.49	-0.02	0.13	0.58	-0.25	-0.22	0.38	0.38	-0.4	-0.2	-0.06	0.1	0.1
Net Receivables	0.91	-0.02	0.81	0.07	-0.64	0.67	0.29	-0.58	-0.1	-0.34		-0.61	0.19	0.75	0.9	0.38	0.11	0.69	0.24	0.14	0.15	0.33	0.72	0.6	0.88	0.88
Common Stock Shares Outstanding	-0.63	-0.14	-0.54	-0.57	0.44	-0.45	-0.37	0.61	0.19	-0.35	-0.61		-0.37	-0.25	-0.67	-0.42	-0.57	-0.31	-0.32	-0.44	-0.45	0.25	-0.26	-0.24	-0.73	-0.73
Short Term Investments	0.55	-0.16	0.55	0.14	0.09	0.47	-0.07	-0.28	0.24	0.52	0.19	-0.37		0.1	0.55	0.16	0.11	0.19	-0.29	-0.18	-0.17	0.03	0.26	0.26	0.52	0.52
Non Current Liabilities Total	0.72	0.05	0.73	-0.3	-0.51	0.7	0.06	-0.67	0.11	-0.49	0.75	-0.25	0.1		0.6	0.12	-0.08	0.46	0.2	-0.03	-0.04	0.31	0.49	0.34	0.54	0.54
Other Stockholder Equity	0.96	-0.06	0.88	0.22	-0.54	0.7	0.22	-0.55	0.02	-0.02	0.9	-0.67	0.55	0.6		0.32	0.22	0.57	0.13	0.03	0.05	0.23	0.72	0.58	0.98	0.98
Total Liab	0.35	0.32	0.3	0.27	-0.3	0.35	-0.14	-0.19	0.09	0.13	0.38	-0.42	0.16	0.12	0.32		0.31	0.81	0.19	0.13	0.1	-0.12	-0.01	0.17	0.4	0.4
Property Plant And Equipment Gross	0.1	0.48	0.13	0.81	-0.41	0.1	0.09	-0.28	-0.04	0.58	0.11	-0.57	0.11	-0.08	0.22	0.31		-0.05	0.46	0.35	0.34	-0.7	-0.17	-0.17	0.38	0.38
Total Current Assets	0.63	-0.02	0.52	-0.08	-0.35	0.5	0.03	-0.31	-0.02	-0.25	0.69	-0.31	0.19	0.46	0.57	0.81	-0.05		0.04	0.05	0.04	0.35	0.45	0.55	0.58	0.57
Cash	0.18	0.73	0.32	0.61	-0.88	0.44	-0.38	0.08	0.43	-0.22	0.24	-0.32	-0.29	0.2	0.13	0.19	0.46	0.04		-0.21	-0.22	-0.59	-0.34	-0.16	0.14	0.14
Other Current Liab	-0.08	-0.28	-0.29	0.0	0.23	-0.41	0.84	-0.61	-0.86	0.38	0.14	-0.44	-0.18	-0.03	0.03	0.13	0.35	0.05	-0.21		1.0	0.1	0.28	0.29	0.18	0.18
Total Current Liabilities	-0.07	-0.32	-0.28	0.01	0.23	-0.42	0.87	-0.6	-0.89	0.38	0.15	-0.45	-0.17	-0.04	0.05	0.1	0.34	0.04	-0.22	1.0		0.11	0.32	0.3	0.2	0.2
Other Liab	0.23	-0.72	0.07	-0.76	0.3	-0.08	0.38	-0.18	-0.36	-0.4	0.33	0.25	0.03	0.31	0.23	-0.12	-0.7	0.35	-0.59	0.1	0.11		0.66	0.55	0.15	0.15
Accounts Payable	0.64	-0.57	0.43	-0.29	-0.08	0.17	0.62	-0.51	-0.47	-0.2	0.72	-0.26	0.26	0.49	0.72	-0.01	-0.17	0.45	-0.34	0.28	0.32	0.66		0.76	0.69	0.69
Long Term Debt	0.55	-0.29	0.38	-0.26	-0.13	0.21	0.48	-0.41	-0.39	-0.06	0.6	-0.24	0.26	0.34	0.58	0.17	-0.17	0.55	-0.16	0.29	0.3	0.55	0.76		0.58	0.58
Common Stock Total Equity	0.91	-0.01	0.81	0.3	-0.53	0.63	0.29	-0.61	-0.07	0.1	0.88	-0.73	0.52	0.54	0.98	0.4	0.38	0.58	0.14	0.18	0.2	0.15	0.69	0.58		1.0
Common Stock	0.91	-0.01	0.81	0.3	-0.53	0.63	0.3	-0.61	-0.08	0.1	0.88	-0.73	0.52	0.54	0.98	0.4	0.38	0.57	0.14	0.18	0.2	0.15	0.69	0.58	1.0

Click cells to compare fundamentals

AMERISAFE Account Relationship Matchups

AMERISAFE fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.5B	1.5B	1.4B	1.3B	1.2B	1.2B
Total Stockholder Equity	430.2M	438.8M	399.3M	317.4M	292.5M	299.4M
Property Plant And Equipment Net	6.3M	6.5M	6.7M	7.3M	6.3M	7.2M
Net Debt	(43.3M)	(61.3M)	(70.3M)	(61.1M)	(38.7M)	(40.6M)
Retained Earnings	227.2M	224.6M	190.5M	145.5M	114.3M	152.8M
Non Current Assets Total	1.1B	1.1B	1.0B	896.3M	2.5B	2.6B
Non Currrent Assets Other	(1.1B)	(1.1B)	(1.0B)	(40.2M)	(1.7B)	(1.6B)
Other Assets	63.9M	51.3M	57.1M	(281.0M)	(1.9B)	(1.8B)
Cash And Short Term Investments	43.8M	61.8M	70.7M	61.5M	355.7M	373.5M
Net Receivables	253.9M	262.6M	255.7M	257.3M	272.9M	252.8M
Common Stock Shares Outstanding	19.3M	19.4M	19.4M	19.3M	19.2M	16.9M
Short Term Investments	497.7M	460.2M	399.2M	335.2M	317.1M	346.9M
Liabilities And Stockholders Equity	1.5B	1.5B	1.4B	1.3B	1.2B	1.2B
Non Current Liabilities Total	1.1B	1.0B	997.0M	38.1M	936.7M	585.5M
Other Stockholder Equity	190.6M	192.9M	195.1M	185.5M	185.1M	164.0M
Total Liab	40.1M	38.9M	37.9M	951.8M	936.7M	811.6M
Property Plant And Equipment Gross	6.1M	6.3M	6.3M	6.5M	7.5M	7.1M
Total Current Assets	297.7M	324.3M	326.4M	654.0M	628.6M	433.5M
Cash	43.8M	61.8M	70.7M	61.5M	38.7M	65.1M
Other Current Liab	(40.1M)	(417K)	(44.3M)	(39.5M)	544.0M	571.2M
Total Current Liabilities	40.1M	38.9M	37.9M	38.1M	544.0M	571.2M
Other Liab	642.5M	902.8M	882.3M	798.8M	918.6M	468.7M
Accounts Payable	40.1M	38.9M	37.9M	38.1M	43.8M	32.9M
Long Term Debt	37.9M	43.4M	42.9M	48.8M	56.1M	38.6M
Accumulated Other Comprehensive Income	12.2M	21.0M	13.5M	(13.8M)	(7.2M)	(6.8M)
Property Plant Equipment	6.3M	6.2M	6.5M	7.2M	8.3M	7.2M
Other Current Assets	345.2M	397.9M	379.9M	276.9M	271.6M	298.6M
Net Tangible Assets	430.2M	438.8M	399.3M	317.4M	285.7M	328.5M
Good Will	1.1B	1.1B	987.8M	816.9M	939.4M	986.4M
Retained Earnings Total Equity	227.2M	224.6M	190.5M	145.5M	131.0M	179.9M
Long Term Debt Total	37.9M	43.4M	42.9M	48.8M	56.1M	43.7M
Capital Surpluse	213.0M	215.3M	217.5M	220.3M	253.3M	226.0M
Inventory	(345.2M)	(397.9M)	(379.9M)	68.2M	(271.6M)	(258.0M)
Long Term Investments	1.1B	1.1B	1.0B	897.4M	857.8M	1.1B
Non Current Liabilities Other	1.0B	988.2M	960.5M	903.0M	1.0B	1.1B
Intangible Assets	19.0M	17.8M	17.1M	17.4M	18.0M	19.1M

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether AMERISAFE is a strong investment it is important to analyze AMERISAFE's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AMERISAFE's future performance. For an informed investment choice regarding AMERISAFE Stock, refer to the following important reports:

How To Invest In AMERISAFE

Details

Is AMERISAFE Stock a good investment?

Details

What is AMERISAFE's Net Worth?

Details

Largest Property & Casualty Insurance Companies

View

Largest Insurance - Specialty Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AMERISAFE. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more detail on how to invest in AMERISAFE Stock please use our How to Invest in AMERISAFE guide.

You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Is Property & Casualty Insurance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AMERISAFE. If investors know AMERISAFE will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AMERISAFE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.443

Dividend Share

1.45

Earnings Share

3.21

Revenue Per Share

16.5

Quarterly Revenue Growth

0.083

The market value of AMERISAFE is measured differently than its book value, which is the value of AMERISAFE that is recorded on the company's balance sheet. Investors also form their own opinion of AMERISAFE's value that differs from its market value or its book value, called intrinsic value, which is AMERISAFE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AMERISAFE's market value can be influenced by many factors that don't directly affect AMERISAFE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AMERISAFE's value and its price as these two are different measures arrived at by different means. Investors typically determine if AMERISAFE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AMERISAFE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

AMERISAFE Current Deferred Revenue vs Capital Surpluse Analysis

Current Deferred Revenue vs Capital Surpluse

Current Deferred Revenue vs Capital Surpluse Correlation Analysis

Correlation Coefficient

Current Deferred Revenue

Capital Surpluse

AMERISAFE fundamental ratios Correlations

AMERISAFE Account Relationship Matchups

High Positive Relationship

High Negative Relationship

AMERISAFE fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Other Current Liab
Common Stock	+ 1.0	Common Stock Total Equity
Common Stock Total Equity	+ 0.98	Other Stockholder Equity
Common Stock	+ 0.98	Other Stockholder Equity
Other Stockholder Equity	+ 0.96	Total Assets
Total Stockholder Equity	+ 0.95	Total Assets

Other Assets	- 0.95	Non Current Assets Total
Total Current Liabilities	- 0.89	Other Assets
Cash	- 0.88	Net Debt
Other Current Liab	- 0.86	Other Assets
Other Liab	- 0.76	Property Plant And Equipment Net
Common Stock	- 0.73	Common Stock Shares Outstanding